Abstract:BackgroundAutism spectrum disorder (ASD) is one of the most highly heritable neuropsychiatric disorders, but underlying molecular mechanisms are still unresolved due to extreme locus heterogeneity. Leveraging meaningful endophenotypes or biomarkers may be an effective strategy to reduce heterogeneity to identify novel ASD genes. Numerous lines of evidence suggest a link between hyperserotonemia, i.e., elevated serotonin (5-hydroxytryptamine or 5-HT) in whole blood, and ASD. However, the genetic determinants of blood 5-HT level and their relationship to ASD are largely unknown.MethodsIn this study, pursuing the hypothesis that de novo variants (DNVs) and rare risk alleles acting in a recessive mode may play an important role in predisposition of hyperserotonemia in people with ASD, we carried out whole exome sequencing (WES) in 116 ASD parent-proband trios with most (107) probands having 5-HT measurements.ResultsCombined with published ASD DNVs, we identified USP15 as having recurrent de novo loss of function mutations and discovered evidence supporting two other known genes with recurrent DNVs (FOXP1 and KDM5B). Genes harboring functional DNVs significantly overlap with functional/disease gene sets known to be involved in ASD etiology, including FMRP targets and synaptic formation and transcriptional regulation genes. We grouped the probands into High-5HT and Normal-5HT groups based on normalized serotonin levels, and used network-based gene set enrichment analysis (NGSEA) to identify novel hyperserotonemia-related ASD genes based on LoF and missense DNVs. We found enrichment in the High-5HT group for a gene network module (DAWN-1) previously implicated in ASD, and this points to the TGF-β pathway and cell junction processes. Through analysis of rare recessively acting variants (RAVs), we also found that rare compound heterozygotes (CHs) in the High-5HT group were enriched for loci in an ASD-associated gene set. Finally, we carried out rare variant group-wise transmission disequilibrium tests (gTDT) and observed significant association of rare variants in genes encoding a subset of the serotonin pathway with ASD.ConclusionsOur study identified USP15 as a novel gene implicated in ASD based on recurrent DNVs. It also demonstrates the potential value of 5-HT as an effective endophenotype for gene discovery in ASD, and the effectiveness of this strategy needs to be further explored in studies of larger sample sizes.

Leveraging blood serotonin as an endophenotype to identify de novo and rare variants involved in autism

Variants of the serotonin transporter gene (SLC6A4) significantly contribute to hyperserotonemia in autism

Autism spectrum disorder associated with low serotonin in CSF and mutations in the SLC29A4 plasma membrane monoamine transporter (PMAT) gene

Developmental Dopaminergic Signaling Modulates Neural Circuit Formation and Contributes to Autism Spectrum Disorder- Related Phenotypes

Brain hyperserotonemia causes autism-relevant social deficits in mice

Identification of De Novo Mutations in the Chinese ASD Cohort Via Whole-Exome Sequencing Unveils Brain Regions Implicated in Autism

Genomic analysis of 116 autism families strengthens known risk genes and highlights promising candidates

Prevalence and phenotypic impact of rare potentially damaging variants in autism spectrum disorder

Unveiling promising drug targets for autism spectrum disorder: insights from genetics, transcriptomics, and proteomics

Inherited and De Novo Genetic Risk for Autism Impacts Shared Networks

Impaired Neurodevelopmental Genes in Slovenian Autistic Children Elucidate the Comorbidity of Autism With Other Developmental Disorders

Evidence that ITGB3 promoter variants increase serotonin blood levels by regulating platelet serotonin transporter trafficking

variants cause autism spectrum disorder the downregulation of WNT/β-catenin signaling pathway

Progress towards understanding risk factor mechanisms in the development of autism spectrum disorders

Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouse

Common risk variants identified in autism spectrum disorder

eQTL colocalization analysis highlights novel susceptibility genes in Autism Spectrum Disorders (ASD)

Targeted Resequencing of 358 Candidate Genes for Autism Spectrum Disorder in a Chinese Cohort Reveals Diagnostic Potential and Genotype-Phenotype Correlations

Causal Metabolomic and Lipidomic Analysis of Circulating Plasma Metabolites in Autism: A Comprehensive Mendelian Randomization Study with Independent Cohort Validation

SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: A study from an Indian population

De Novo Insertions and Deletions of Predominantly Paternal Origin Are Associated with Autism Spectrum Disorder.